• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Cynosure Inc.

Cynosure launches next-generation aesthetic laser device

June 1, 2022 By Sean Whooley

Cynosure announced today that it launched the PicoSure Pro device, its latest upgrade to the PicoSure platform. PicoSure Pro, the first and only FDA-cleared 755nm picosecond laser on the market, delivers energy in one trillionth of a second, utilizing pressure instead of heat to provide safe and effective treatments for unwanted pigmentation and skin revitalization […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic Tagged With: Cynosure Inc.

Cynosure names EVP of R&D

October 19, 2020 By Sean Whooley

Cynosure announced today that it appointed Sujat Sukthankar as its executive VP of research & product development, effective today. Westford, Mass.-based Cynosure said in a news release that Sukthankar will report to CEO Todd Tillemans and will work to enhance the company’s R&D team. “There is no better person to help drive category growth than […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic Tagged With: Cynosure Inc., Personnel Moves

Hologic to sell Cynosure medical aesthetics business for $205m

November 20, 2019 By Sean Whooley

Hologic (NSDQ:HOLX) announced today that it entered into a definitive agreement to sell its Cynosure medical aesthetics business in a deal worth more than $200 million. The Marlborough, Mass.–based company is in agreement with an affiliate of investment funds managed by Clayton, Dubilier & Rice and expected to collect net cash proceeds of approximately $138 million, according […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic, Featured, Gynecological, Mergers & Acquisitions, Women's Health Tagged With: Cynosure Inc., Hologic

Hologic lowers Cynosure revenue outlook in response to FDA warning on ‘vaginal rejuvenation’ products

September 13, 2018 By Fink Densford

Hologic (NSDQ:HOLX) today lowered the revenue expectations for its Cynosure division by $15 million to take into effect lost and reduced sales associated with an FDA warning from last month which raised concerns about the validity and functionality of “vaginal rejuvenation” products and procedures. Last month the company said that Cynosure will suspend the marketing and […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: Cynosure Inc., Hologic

Hologic pulls Vitalia handpieces, probes in light of FDA concerns over vaginal rejuv tech

August 13, 2018 By Fink Densford

Hologic (NSDQ:HOLX) said today that its subsidiary Cynosure is suspending marketing and distribution of its TempSure Vitalia handpieces and probes after the FDA released a warning about a lack of evidence to support certain “vaginal rejuvenation” products late last month. The Marlborough, Mass.-based company said that it takes “the FDA’s recent statements very seriously” and […]

Filed Under: Business/Financial News, Cosmetic/Aesthetic, Women's Health Tagged With: Cynosure Inc., Hologic

Inside Hologic’s evolving definition of women’s healthcare

August 13, 2018 By Sarah Faulkner

Hologic (NSDQ:HOLX), known in the medtech industry for its mammography and diagnostics devices, is rethinking what it means to be a women’s healthcare company. The 6,000-person company wants to expand its reach to include products that care for women’s well-being, as well as their health – a concept that Dr. Edward Evantash honed when he led […]

Filed Under: Business/Financial News, Food & Drug Administration (FDA), Women's Health Tagged With: Cynosure Inc., Hologic

Hologic’s Cynosure to close NY-based plant, layoff 30

August 7, 2018 By Fink Densford

Hologic (NSDQ:HOLX) subsidiary Cynosure is looking to lay off 30 workers at its Hicksville, N.Y.-based facilities, according to a newly released Worker Adjustment and Retraining Notification act posting. The layoffs come as a result of the company closing its plant, which produced “irradiation apparatus” devices, according to the notice. Hologic will move the production jobs to […]

Filed Under: Business/Financial News Tagged With: Cynosure Inc., Hologic

FDA warns on ‘vaginal rejuvenation’ procedures

July 31, 2018 By Fink Densford

FDA head Dr. Scott Gottlieb today released a statement warning about “vaginal rejuvenation” procedures intended to treat conditions related to menopause, urinary incontinence or sexual function, saying that the products used in the procedures “don’t have adequate evidence to support their use for this purpose.” Gottliebb said that the procedures use lasers or energy-based devices […]

Filed Under: Food & Drug Administration (FDA), Women's Health Tagged With: Alma Lasers, Cynosure Inc., InMode Aesthetic Solutions, sciton

Hologic wins expanded FDA nod for Cynosure SculpSure

September 28, 2017 By Fink Densford

Hologic (NSDQ:HOLX) said today it won expanded FDA 510(k) clearance for its subsidiary Cynosure’s SculpSure non-invasive body contouring laser, now cleared to treat the submental area. The new treatment indication expands the total for the company to 6, as the device is already cleared to treat the abdomen, flanks, back, inner and outer thighs, the Marlborough, […]

Filed Under: Cosmetic/Aesthetic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Cynosure Inc., Hologic

Medtech M&A: The 10 biggest deals so far in 2017

June 29, 2017 By Fink Densford

Over the past several years, the healthcare industry as a whole has experienced an abundance of mergers and acquisitions – major players are buying up their peers in deals ranging from millions to billions.  The trend is continuing, and the healthcare playing field continues to be shaped by these mega-transactions. For the medical device industry, […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11

Filed Under: Blog, Business/Financial News, Mergers & Acquisitions Tagged With: Abbott, becton dickinson, Boston Scientific, C.R. Bard, Cardinal Health, Codman Neuro, Cynosure Inc., Edwards Lifesciences, Hologic, Integra LifeSciences, Johnson and Johnson, Medtronic, Novadaq, stjudemedical, Stryker, Symetis, Teleflex, Valtech Cardio, vascularsolutions

Hologic’s Cynosure wins FDA expanded indications for SculpSure

June 15, 2017 By Fink Densford

Hologic (NSDQ:HOLX) said today its Cynosure subsidiary won expanded clearance from the FDA for its non-invasive SculpSure body contouring device. With the expanded indication, the SculpSure is now cleared for treatments of the back and inner and outer thighs, the Marlborough, Mass.-based company said. The device is already cleared for treatment of the abdomen and flanks. The […]

Filed Under: Cosmetic/Aesthetic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Cynosure Inc., Hologic

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 6
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy